An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty

American Heart Journal

Volumn 145, Issue 3, 2003, Pages 404-408

  Dens, J ^a   Desmet, W ^a   Piessens, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NIFEDIPINE; NISOLDIPINE; NITRIC OXIDE SYNTHASE; PLACEBO; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERAPAMIL;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0037350576     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.171     Document Type: Article

References (29)

1. Hillegass WB, Ohman EM, Leimberg JD, et al. A meta-analysis af randomized trials of calcium channel antaganists to reduce restenosis after caranary angiaplasty. Am J Cardial 1994;73:835-9.
2. Dens J, Desmet W, Coussement P, et al. Usefulness of nisoldipine for prevention af restenasis after percutaneaus transluminal coranary angioplasty (results of the NICOLE study). Am J Cardiol 2001;87:28-33.
3. Järgensen B, Simonsen S, Endresen K, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results fram the Coranary AngioPlasty/Amlodipine Restenasis Study (CAPARES). J Am Call Cardiol 2000;35:592-9.
4. Corcas T, David PR, Val PG, et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal angioplasty. Am Heart J 1985;109:926-31.
5. Whitworth H, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
6. Hoberg E, Dietz R, Frees U, et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J 1994;71:254-60.
7. O'Keefe JH, Giorgi LV, Hartzler GO, et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991;67:373-6.
8. Unverdorben M, Leucht M, Kunkel B, et al. Diltiazem reduces restenosis after percutaneous transluminal coronary angioplasty. J Interv Cardiol 1996;9:287-95.
9. Matthews DE, Farewell V. Using and understanding medical statistics. Basel: Karger; 1985. p. 139-47.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
11. Breslow NE, Day NE. Statistical methods in cancer research. In: The analysis of case control studies. Vol I. Lyon: IARC Scientific Publications; 1980. p. 136-46.
12. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988;77:361-71.
13. Scott N, Wilcox J. Editorial: the role of adventitial vasculature in restenosis: a new view of an old problem. J Am Coll Cardiol 1998;32:7:2080.
14. Shi Y, Pieniek M, Fard A, et al. Adventitial remodeling after coronary arterial injury. Circulation 1996;93:340-8.
15. Lafont A, Guerot C, Lemarchand P. Which gene for which restenosis? Lancet 1995;346:1442-3.
16. Christiansen S, Schmidt M, Danielsen C, et al. Inhibition of collagen cross-linking reduces (re) stenosis in porcine model [abstract]. Circulatian 1997;96(1 Suppl):1-548.
17. Libby P, Sukhova G, Kranzhofer R, et al. Cellular activation in restenosis following angioplasty. Atherosclerosis 1995;10:690-3.
18. Hermans W, Rensing B, Strauss B, et al. Prevention of restenosis after percutaneaus transluminal angioplasty: the search for a "magic bullet." Curriculum Cardial 1991;122:171-87.
19. Hisashi Y, Hirayuki D, Yoichi K, et al. Effectiveness af an antiaxidant in preventing restenosis after percutaneous transluminal caronary angioplasty: the probucol angioplasty restenosis trial. J Coll Cardiol 1997;30:855-62.
20. Tamai H, Katoh O, Suzuki S, et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis following angioplasty Trial (TREAT). Am Heart J 1999;138:968-75.
21. Yang Z, Noll G, Luscher TF. Calcium channel antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet derived grawth factor. Circulation 1993;88:832-6.
22. McMurray HF, Chahwala SB. Amlodipine excites a potent antimigrational effect on aortic smoath muscle cells in culture. J Cardiovasc Pharmacol 1992;20(A Suppl):54-6.
23. Voisard R, Koschnick S, Baur R, et al. High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis. Coron Artery Dis 1997;8:189-201.
24. Kiyomoto A, Sasaki Y, Odawara A, et al. Inhibition of platelet aggregation by diltiazem: comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites. Circ Res 1983;52(1 Suppl):1-115-9.
25. Ikeda Y, Kikuchi M, Toyama K, et al. Inhibition of human platelet functions by verapamil. Thromb Haemast 1981;45:158-61.
26. Hernandez R, Carvajal AR, Armas-de Hernandez MJ, et al. The effects of calcium channel antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients. Postgrad Med J 1991;67(5 Suppl):S38-40.
27. Libby P, Ganz P. Editorial: restenosis revisited: new targets, new therapies. N Engl J Med 1997;337:418-9.
28. Hasdai D, Lerman A, Grill DE, et al. Medical therapy after successful percutaneous coronary revascularization. Ann Intern Med 1999;130:108-15.
29. Blumenthal R, Cohn G, Schulman S. Medical therapy versus coronary angioplasty in stable coronary artery diseose: a critical review of the literature. J Am Coll Cardiol 2000;36:668-73.